Home/Pipeline/SiRx‑Immunology

SiRx‑Immunology

Immunology

DiscoveryActive

Key Facts

Indication

Immunology

Phase

Discovery

Status

Active

Company

About SiCare Bio

SiCare Bio offers a nano‑silica drug‑delivery platform for precise, sustained release of therapeutics.

View full company profile

Therapeutic Areas

Ophthalmology Oncology Immunology Contraception Neurology

Other Immunology Drugs

Drug	Company	Phase	Status
PRT-004	Protai	Preclinical	Active
Biosimilars Pipeline (Immunology Focus)	Aurobindo Pharma	Development	Active
ABBV-706	AbbVie	Phase 1	Active